Trials / Not Yet Recruiting
Not Yet RecruitingNCT07103278
A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers
An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers Under Fasting Conditions
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (estimated)
- Sponsor
- Addpharma Inc. · Industry
- Sex
- Male
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The study compare and evaluate the safety and pharmacokinetic characteristics between the administration of AD-116 and the administration of AD-1161 in healthy adult male volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD-116 | AD-116 Oral Tablet |
| DRUG | AD-1161 | AD-1161 Oral Capsule |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2026-01-01
- Completion
- 2026-01-01
- First posted
- 2025-08-05
- Last updated
- 2025-10-03
Source: ClinicalTrials.gov record NCT07103278. Inclusion in this directory is not an endorsement.